Form 6-K ASTRAZENECA PLC For: Aug 14
http://archive.fast-edgar.com/20140819/A22ZA22CZ22W82Z222282CDZNTJAZZM2DJ62
Filed on: August 19, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
- AstraZeneca's (AZN) Truqap plus Faslodex approved in Japan for patients with advanced HR-positive breast cancer
- FendX Continues to Advance Optimization of REPELWRAP(TM) Film with Completion of Pilot Manufacturing Run on Dunmore's Commercial Manufacturing Equipment and Provides Corporate Update
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!